14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
While the country faces the COVID-19 pandemic, highway and transportation construction is almost uni...
Read More >
Arnall Golden Gregory LLP is pleased to provide you with the Compliance News Flash, which includes c...
Read More >
In a June 14, 2019 decision, the National Labor Relations Board clarified whether an employer may li...
Read More >
The UK Supreme Court on July 3 issued its judgment in Tillman v Egon Zehnder Ltd, reversing the deci...
Read More >
Welcome back to the Law School Toolbox podcast! Today, we have ex-BigLaw recruiter Sadie Jones back ...
Read More >
In Ariana M. v. Humana Health Plan of Texas, Inc., No. 18-20700, 2019 WL 5866677 (5th Cir. Nov. 8, 2...
Read More >